Atrial fibrillation ablation in patients undergoing aortic valve replacement

Journal of Heart Valve Disease

Volumn 21, Issue 3, 2012, Pages 350-357

  Malaisrie, S Chris ^a   Lee, Richard ^a   Kruse, Jane ^a   Lapin, Brittany ^a   Wang, Edward C ^a   Bonow, Robert O ^a   McCarthy, Patrick M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; WARFARIN; ANTICOAGULANT AGENT;

ABLATION THERAPY; ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; SINUS RHYTHM; AORTA VALVE; CATHETER ABLATION; COMORBIDITY; DISEASE FREE SURVIVAL; HEART MUSCLE ISCHEMIA; HEART VALVE REPLACEMENT; METHODOLOGY; MIDDLE AGED; STATISTICS; SURVIVAL RATE; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; AORTIC VALVE; ATRIAL FIBRILLATION; CATHETER ABLATION; COMORBIDITY; CORONARY ARTERY BYPASS; DISEASE-FREE SURVIVAL; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866035508     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998;158:229-234
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457
3. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007;4:816-861
4. Ambler G, Omar RZ, Royston P, Kinsman R, Keogh BE, Taylor KM. Generic, simple risk stratification model for heart valve surgery. Circulation 2005;112:224-231
5. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003;24:881-882
6. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in- valve implantation for failed bioprosthetic heart valves. Circulation 2010;121:1848-1857
7. McCarthy PM, Kruse J, Shalli S, et al. Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J Thorac Cardiovasc Surg 2010;139:860-867
8. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final data for 2007. National Vital Statistics Reports 2010;58:1-136
9. Banbury MK, Cosgrove DM, III, Lytle BW, Smedira NG, Sabik JF, Saunders CR. Long-term results of the Carpentier-Edwards pericardial aortic valve: A 12-year follow-up. Ann Thorac Surg 1998;66:S73-S76
10. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231
11. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268
12. Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg 2005;27:258-265
13. Gammie JS, Haddad M, Milford-Beland S, et al. Atrial fibrillation correction surgery: Lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg 2008;85:909-914
14. Schulenberg R, Antonitsis P, Stroebel A, Westaby S. Chronic atrial fibrillation is associated with reduced survival after aortic and double valve replacement. Ann Thorac Surg 2010;89:738-744
15. Ngaage DL, Schaff HV, Barnes SA, et al. Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: Is there an argument for concomitant arrhythmia surgery? Ann Thorac Surg 2006;82:1392-1399
16. Gillinov AM, Saltman AE. Ablation of atrial fibrillation with concomitant cardiac surgery. Semin Thorac Cardiovasc Surg 2007;19:25-32
17. Bando K, Kobayashi J, Sasako Y, Tagusari O, Niwaya K, Kitamura S. Effect of maze procedure in patients with atrial fibrillation undergoing valve replacement. J Heart Valve Dis 2002;11:719-724; discussion 725
18. Geidel S, Lass M, Ostermeyer J. A 5-year clinical experience with bipolar radiofrequency ablation for permanent atrial fibrillation concomitant to coronary artery bypass grafting and aortic valve surgery. Interact Cardiovasc Thorac Surg 2008;7:777-780
19. Khargi K, Lemke B, Deneke T. Concomitant antiarrhythmic procedures to treat permanent atrial fibrillation in CABG and AVR patients are as effective as in mitral valve patients. Eur J Cardiothorac Surg 2005;27:841-846